This inventor holds 8 USPTO granted patents and 1 published patent application, plus 2 CIPO patents. Top assignees: Johns Hopkins University, La Jolla Biosciences LLC. Active years: 1999-2009.
Location History:
- Woodstock, MD (US) (2006)
- Baltimore, MD (US) (1999 - 2009)
Company Filing History:
8 out of 3,790 
1 out of 1 Years Active: 1999-2009
Title: James E. Hildreth: Innovator in Chiral Integrin Modulators
Introduction
James E. Hildreth is an accomplished inventor based in the United States. He has made significant contributions to the field of pharmaceuticals, particularly in the development of chiral integrin modulators. His work focuses on innovative solutions for treating various disorders and conditions.
Latest Patents
James E. Hildreth holds a notable patent titled "Chiral Integrin Modulators And Methods Of Use Thereof." This invention provides enantiomers of ajoene and derivatives of Z(-)-ajoene. The derivatives of Z(-)-ajoene are useful for modulating integrin-mediated functions, which can aid in treating disorders, diseases, or conditions where integrins play a crucial role. Additionally, these compounds can improve tissue conditions for subsequent uses, such as transplantation.
Career Highlights
James E. Hildreth is currently associated with Billings Pharmaceuticals, Inc. His work at the company emphasizes the importance of innovative pharmaceutical solutions. Despite having no patents listed under his name, his research and development efforts contribute significantly to the field.
Collaborations
James has collaborated with notable colleagues, including John B. Davidson and Alexander V. Tatarintsev. These partnerships enhance the scope and impact of his research endeavors.
Conclusion
James E. Hildreth is a dedicated inventor whose work in chiral integrin modulators showcases his commitment to advancing pharmaceutical science. His contributions, although not extensive in patent numbers, reflect a deep understanding of integrin-mediated functions and their applications in medicine.